Valentin P. Yakubenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Valentin P. Yakubenko has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Aleksey Schurin
Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195
1 shared publicationAshish Bhattacharjee
Department of Cell Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA
1 shared publicationDaria Mishchuk
§the Center for Metabolic Biology, Arizona State University, AZ, 85287
1 shared publicationElzbieta Pluskota
¶ Department of Molecular Cardiology, Cleveland Clinic, Cleveland, OH 44195, USA
1 shared publication- Martha K. Cathcart
Department of Cell Biology, Cleveland Clinic, Cleveland, OH 44195
1 shared publication Nataly Belevych
Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195
1 shared publication
Latest Publications
- 4 March 2011
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 108 (5) , 544-554
α M β 2 Integrin Activation Prevents Alternative Activation of Human and Murine Macrophages and Impedes Foam Cell Formation
Rationale:: The alternative activation of monocytes by interleukin (IL)-13 and IL-4 is a significant component of the inflammatory response. The consequences of alternative activation in inflammatory diseases remain to be determined. Objective:: In this report, we explored how integrins, receptors important for monocyte migration to inflammatory sites, regulate IL-13–mediated monocyte activation. We focused on the analysis of 2 proteins, which are upregulated during the alternative activation and are important for the development of atherosclerosis, an oxidative enzyme 15-lipoxygenase (15-LO) and a scavenger receptor CD36. Methods and Results:: We found that adhesion of resting monocytes through β 2 integrins and inside-out activation of β 2 integrins by monocyte chemoattractant protein-1 did not change IL-13–stimulated 15-LO upregulation; however, preincubation of monocytes with the antibody MEM48, which generates full activation of β 2 integrins, significantly inhibited 15-LO mRNA and protein expression. In contrast, activation of β 1 integrins had no effect on 15-LO expression. Analysis of integrin clustering through α M , α L , α X , and α D subunits demonstrated the pivotal role for integrin α M β 2 in inhibiting 15-LO expression. IL-13 treatment upregulates 15-LO–dependent CD36 expression on human monocytes; our studies showed that β 2 integrin activation and α M integrin clustering significantly inhibited IL-13–dependent CD36 mRNA and protein expression, as well as CD36-related foam cell formation. Moreover, IL-13 stimulation of α M -deficient peritoneal macrophages demonstrated an upregulated level of 15-LO induction, CD36 expression, and lipid accumulation as compared with wild-type controls. Conclusions:: The adhesion of monocytes/macrophages through activated integrin α M β 2 has a regulatory and potential atheroprotective function during the alternative activation of macrophages.
- 4 March 2011
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 108 (5) , 544-554
α M β 2 Integrin Activation Prevents Alternative Activation of Human and Murine Macrophages and Impedes Foam Cell Formation
Rationale:: The alternative activation of monocytes by interleukin (IL)-13 and IL-4 is a significant component of the inflammatory response. The consequences of alternative activation in inflammatory diseases remain to be determined. Objective:: In this report, we explored how integrins, receptors important for monocyte migration to inflammatory sites, regulate IL-13–mediated monocyte activation. We focused on the analysis of 2 proteins, which are upregulated during the alternative activation and are important for the development of atherosclerosis, an oxidative enzyme 15-lipoxygenase (15-LO) and a scavenger receptor CD36. Methods and Results:: We found that adhesion of resting monocytes through β 2 integrins and inside-out activation of β 2 integrins by monocyte chemoattractant protein-1 did not change IL-13–stimulated 15-LO upregulation; however, preincubation of monocytes with the antibody MEM48, which generates full activation of β 2 integrins, significantly inhibited 15-LO mRNA and protein expression. In contrast, activation of β 1 integrins had no effect on 15-LO expression. Analysis of integrin clustering through α M , α L , α X , and α D subunits demonstrated the pivotal role for integrin α M β 2 in inhibiting 15-LO expression. IL-13 treatment upregulates 15-LO–dependent CD36 expression on human monocytes; our studies showed that β 2 integrin activation and α M integrin clustering significantly inhibited IL-13–dependent CD36 mRNA and protein expression, as well as CD36-related foam cell formation. Moreover, IL-13 stimulation of α M -deficient peritoneal macrophages demonstrated an upregulated level of 15-LO induction, CD36 expression, and lipid accumulation as compared with wild-type controls. Conclusions:: The adhesion of monocytes/macrophages through activated integrin α M β 2 has a regulatory and potential atheroprotective function during the alternative activation of macrophages.
- 1 August 2008
- Published by Elsevier in Experimental Cell Research
- Vol. 314 (14) , 2569-2578
The role of integrin αDβ2 (CD11d/CD18) in monocyte/macrophage migration
- 1 August 2008
- Published by Elsevier in Experimental Cell Research
- Vol. 314 (14) , 2569-2578
The role of integrin αDβ2 (CD11d/CD18) in monocyte/macrophage migration